EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma

Maria A Jacome iD, Qiong Wu iD, Yolanda Piña, Arnold B Etame iD

Cancers · 29.10.2024 · 16 (21) · 3635

DOI: 10.3390/cancers16213635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.10.2024. Verfasst von Maria A Jacome und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Morfológicas Microscópicas, Universidad de Carabobo, Valencia 02001, Venezuela. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, National Institute of Neurological Disorders and Strokes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most commonly occurring malignant brain tumor, with a high mortality rate despite current treatments. Its classification has evolved over the years to include not only histopathological features but also molecular findings. Given the heterogeneity of glioblastoma, molecular biomarkers for diagnosis have become essential for initiating treatment with current therapies, while new technologies for detecting specific variations using computational tools are being rapidly developed. Advances in molecular genetics have made possible the creation of tailored therapies based on specific molecular targets, with various degrees of success. This review provides an overview of the latest advances in the fields of histopathology and radiogenomics and the use of molecular markers for management of glioblastoma, as well as the development of new therapies targeting the most common molecular markers. Furthermore, we offer a summary of the results of recent preclinical and clinical trials to recognize the current trends of investigation and understand the possible future directions of molecular targeted therapies in glioblastoma.

Schlagwörter

Stichwörter der Autor:innen

gene therapyglioblastomamolecular biomarkersmolecular targeted therapy

Autor:innen und Institutionen

  • Departamento de Ciencias Morfológicas Microscópicas, Universidad de Carabobo, Valencia 02001, Venezuela.
  • Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

ORCID-Profile: Maria A Jacome, Qiong Wu, Arnold B Etame

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • National Institute of Neurological Disorders and Strokes
  • National Cancer Institute

Zitieren

APA

Jacome, M. A., Wu, Q., Piña, Y., & Etame, A. B. (2024). Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma. Cancers, 16(21), 3635. https://doi.org/10.3390/cancers16213635

Vancouver

Jacome MA, Wu Q, Piña Y, Etame AB. Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma. Cancers. 2024;16(21):3635. doi:10.3390/cancers16213635

BibTeX
@article{Jacome2024,
  author = {Jacome, Maria A and Wu, Qiong and Piña, Yolanda and Etame, Arnold B},
  title = {Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3635},
  doi = {10.3390/cancers16213635}
}
Kostenlos starten →